文献速递炎症性肠病

Synbindin抑制结肠炎中巨噬细胞对菌群的促炎活化

Synbindin restrains proinflammatory macrophage activation against microbiota and mucosal inflammation during colitis.
PubMed 文献 · Gut · 2021-01-13

该研究利用三种synbindin杂合缺失小鼠模型,发现全局性synbindin单倍剂量不足加重DSS结肠炎,且依赖肠道菌群和髓系细胞而非肠上皮细胞。机制上synbindin与Rab7b互作协调TLR4内体降解以终止信号,活动性IBD患者单核细胞和黏膜巨噬细胞中synbindin升高。

要点

  • 髓系细胞synbindin杂合缺失加重DSS结肠炎,依赖肠道菌群。
  • Synbindin通过Rab7b协调TLR4内体降解,终止促炎信号。
  • 活动性IBD患者单核细胞和黏膜巨噬细胞synbindin表达升高。

核心结论

  • Synbindin是TLR4信号的关键调控因子,在结肠炎中抑制巨噬细胞对菌群的促炎活化。

研究设计与样本

  • 构建全局、髓系特异性或肠上皮细胞特异性synbindin杂合缺失小鼠模型,用于DSS结肠炎研究。
  • 评估synbindin对LPS或具核梭杆菌刺激下TLR4信号和巨噬细胞活化的影响。
  • 用免疫荧光和免疫共沉淀确定synbindin与Rab7b的共定位和相互作用。
  • 检测活动性IBD患者循环单核细胞和肠黏膜巨噬细胞中synbindin表达。

主要发现

  • 全局synbindin单倍剂量不足显著加重DSS诱导的肠道炎症。
  • DSS易感性增加可被肠道菌群耗竭消除,并由髓系细胞而非肠上皮细胞synbindin杂合缺失表型复制。
  • Synbindin干扰的巨噬细胞在LPS或具核梭杆菌刺激下出现显著异常的促炎基因特征和过度TLR4信号。
  • DSS结肠炎小鼠和活动性IBD患者的肠黏膜巨噬细胞及循环单核细胞中synbindin显著升高。
  • IL-23和GM-CSF可诱导synbindin表达。

关键数值与推荐

  • Synbindin与Rab7b共定位并直接相互作用,协调TLR4的内体降解途径以终止信号。

临床怎么用

  • Synbindin可能作为活动性IBD中调控巨噬细胞促炎活化的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: As a canonical membrane tethering factor, the function of synbindin has been expanding and indicated in immune response. Here, we investigated the role of synbindin in the regulation of toll-like receptor 4 (TLR4) signalling and macrophage response to microbiota during colitis. DESIGN: Three distinct mouse models allowing global, myeloid-specific or intestinal epithelial cell-specific synbindin heterozygous deletion were constructed and applied to reveal the function of synbindin during dextran sodium sulfate (DSS) colitis. Effects of synbindin on TLR4 signalling and macrophage activation in response to bacterial lipopolysaccharide (LPS) or Fusobacterium nucleatum were evaluated. The colocalisation and interaction between synbindin and Rab7b were determined by immunofluorescence and coimmunoprecipitation. Synbindin expression in circulating monocytes and intestinal mucosal macrophages of patients with active IBD was detected. RESULTS: Global synbindin haploinsufficiency greatly exacerbated DSS-induced intestinal inflammation. The increased susceptibility to DSS was abolished by gut microbiota depletion, while phenocopied by specific synbindin heterozygous deletion in myeloid cells rather than intestinal epithelial cells. Profoundly aberrant proinflammatory gene signatures and excessive TLR4 signalling were observed in macrophages with synbindin interference in response to bacterial LPS or Fusobacterium nucleatum. Synbindin was significantly increased in intestinal mucosal macrophages and circulating monocytes from both mice with DSS colitis and patients with active IBD. Interleukin 23 and granulocyte-macrophage colony-stimulating factor were identified to induce synbindin expression. Mechanistic characterisation indicated that synbindin colocalised and directly interacted with Rab7b, which coordinated the endosomal degradation pathway of TLR4 for signalling termination. CONCLUSION: Synbindin was a key regulator of TLR4 signalling and restrained the proinflammatory macrophage activation against microbiota during colitis.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Ai L, Ren Y, Zhu M, et al. Synbindin restrains proinflammatory macrophage activation against microbiota and mucosal inflammation during colitis. Gut. 2021. PMID: 33441378. doi:10.1136/gutjnl-2020-321094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。